Population
Adults aged 18 or older; general and high-risk populations kept separate when baseline risk differs.
Rules published before the full search, so future decisions can be checked against the plan rather than reconstructed after the result.
The primary question is whether processed or unprocessed red-meat intake is associated with colorectal cancer, type 2 diabetes, cardiovascular events or mortality in adults. Short-term cardiometabolic markers form a separate evidence stream.
Adults aged 18 or older; general and high-risk populations kept separate when baseline risk differs.
Processed and unprocessed red meat recorded separately, including amount, frequency, preparation and product definition.
Lower or zero intake, another intake category, or a named replacement food. An implicit comparator is never relabelled as a substitution.
Colorectal cancer; incident type 2 diabetes; cardiovascular events and all-cause mortality; short-term markers shown separately.
The final strategies will be peer reviewed by an information specialist and published verbatim with platform, execution date and result count. That standard has not yet been reached.
("red meat"[Title/Abstract] OR "processed meat"[Title/Abstract]
OR beef[Title/Abstract] OR pork[Title/Abstract] OR lamb[Title/Abstract]
OR mutton[Title/Abstract])This exposure-led seed remains the starting point for the definitive strategy. The operational v0.3 layer below combines it with outcome concepts, Create Date and a one-day overlap; controlled vocabulary and validated design filters still require information-specialist review.
Create Date targets citations newly created in PubMed, including old publications whose Entry Date can be backdated. The rolling window repeats the previous calendar day so records added after the prior 08:00 run are not skipped. ESummary and EFetch preserve the citation and complete screening material. This remains a discovery layer, not the definitive multi-database search.
(("red meat"[Title/Abstract] OR "processed meat"[Title/Abstract]
OR beef[Title/Abstract] OR pork[Title/Abstract] OR lamb[Title/Abstract]
OR mutton[Title/Abstract])
AND ("colorectal cancer"[Title/Abstract]
OR "colorectal neoplasms"[Title/Abstract]
OR "type 2 diabetes"[Title/Abstract]
OR cardiovascular[Title/Abstract] OR "heart disease"[Title/Abstract]
OR stroke[Title/Abstract] OR mortality[Title/Abstract] OR death[Title/Abstract]
OR LDL[Title/Abstract] OR cholesterol[Title/Abstract]
OR "blood pressure"[Title/Abstract] OR glycemic[Title/Abstract]
OR glucose[Title/Abstract] OR insulin[Title/Abstract]
OR inflammation[Title/Abstract] OR TMAO[Title/Abstract]
OR homocysteine[Title/Abstract] OR cardiometabolic[Title/Abstract]))
AND ("2026/08/12"[Create Date] : "2026/08/13"[Create Date])Narrative review with a broad diet-and-cancer discussion; no eligible primary red-meat contrast.
Tuberculosis burden is outside the prespecified outcomes.
Breast cancer is outside the prespecified outcomes.
Narrative review without an original eligible red-meat contrast or a reproducible systematic-review selection flow.
These are search-flow decisions, not claims that the papers are invalid. Plausibly relevant full-text exclusions remain in the separate screening register.
Combine sources and remove duplicate records.
Two reviewers independently screen titles/abstracts and full texts.
Record one primary reason for each plausibly relevant full-text exclusion.
Join registrations, reports, supplements, corrections and secondary analyses into one study family.
Settle disagreements by consensus or a third reviewer.
Two reviewers check every decision-relevant extraction and appraisal.
Population, exposure measurement, comparator, outcome definition, follow-up, relative and absolute estimates, uncertainty, adjustment set, missing data, sensitivity analyses, funding, conflicts, sponsor role, registration, data/code access and post-publication notices or discussion.
Keep processed and unprocessed meat, outcomes, designs and materially different comparators separate.
Report between-study variance and prediction intervals when estimable; do not replace interpretation with a p-value threshold.
Convert relative effects to absolute effects only with a defensible baseline risk, exposure contrast and time horizon.
Preplanned sensitivity checks cover risk of bias, replacement food, BMI or other mediators, lag periods, outcome definitions, follow-up, sponsor involvement and overlapping study families.
Operational surveillance runs daily. A new record is screened against the same criteria; the public conclusion changes only after eligibility, appraisal and human review. Silence is not an update: an unchanged conclusion is logged too.
An eligible source can materially change an effect estimate, certainty or decision boundary.
A correction, expression of concern, retraction or substantive formal discussion appears.
A protocol rule changes; the amendment is dated and explained before reuse.
A material limitation, funding relationship or data/code status was missing or misstated.
0.8 · 13 August 2026 — made English and Italian improvement summaries separate required receipt fields; finalization fails if either is missing or undersized, and each protocol renders only its matching language. · 0.7 — bound editorial completion to the exact successful automated receipt. A failed control or later same-day rerun now invalidates the prior editorial state until that specific receipt is finalized. · 0.6 — added an atomic command-driven editorial finalizer with explicit counts and yes/no declarations. · 0.5 — added a date-matched editorial receipt; stale completion is exposed as pending. · 0.4 — changed the operational date field to Create Date and added a one-day rolling overlap. · 0.3 — added complete MEDLINE records and hard completeness checks. · 0.2 — added the first Entry Date query and machine-readable receipt. · 0.1 — first public draft.